Open Access Journals Promotions

Submit Manuscript Other Thematic Issue Proposal Browse Thematic Issue Become a Reviewer
Share this:

Visibility on Science Direct (Elsevier) also if published as Open Access.

Member Institutions enjoy complementary or discounted APCs.

Quick and simple submission process.

Targeting Enzymes For Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Guest Editor(s): Dr. Guang Huang
Co-Guest Editor(s):
Submission closes on: 26th January, 2026

Submit Manuscript
Impact Factor Current: 2.6
5 - Year: 2.5
View Impact Factor Journals
Scopus CiteScore5.1 View Details

Introduction

Enzymes are essential to numerous cellular processes, and their dysregulation often drives tumor progression and metastasis. Consequently, targeting specific enzymes has emerged as a promising therapeutic approach in oncology. This thematic issue, Targeting Enzymes for Cancer Therapy, will explore the latest advancements and challenges in the discovery, development, and application of enzyme-targeted treatments for various cancers. The issue will feature articles on a diverse array of topics, including the innovative design and synthesis of enzyme inhibitors and degraders, bioactivity evaluations, and their potential therapeutic applications in oncology. By showcasing cutting-edge strategies and methodologies, this issue aims to engage researchers in medicinal chemistry, biochemistry, and drug development. We invite high-quality reviews and original research articles for this Special Issue, which aspires to be a valuable resource for advancing enzyme-based cancer therapies.

Keywords

Enzymes, Kinases, Cancer, Anticancer, Drug design and discovery, Inhibitors, Degraders, Mechanism.

Sub-topics

  • Design, synthesis, and discovery of enzyme inhibitors and degraders
  • Structural and mechanistic insights into enzymes as cancer targets
  • Novel therapeutic approaches targeting kinases, histone methyltransferases, deacetylases, and other critical enzymes involved in cancer pathways
  • Advances in computational methods and high-throughput screening to identify enzyme-targeted lead/drug candidates
  • Advances in Medicinal Chemistry
  • Application of privileged scaffolds in drug design and development
© 2025 Bentham Science Publishers | Privacy Policy